Bruker (BRKR) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Bruker (BRKR) do?
Bruker Corp (BRKR) is a U.S.-listed company in Healthcare (Medical Devices). What it does: Sells analytical instruments like nuclear magnetic resonance spectrometers, mass spectrometers, and advanced microscopes. It manufactures scientific instruments and diagnostic tools used to analyze materials at molecular, cellular, and. It is worth $9.48B on the market and sold $3.51B over the last year.
- Market cap
- $9.48B
- P/E ratio
- None (reported a loss)
- Annual sales
- $3.51B
- Sector
- Healthcare
- Industry
- Medical Devices
- Brief updated
- Nov 18, 2026
Brands and businesses behind BRKR
- MALDI Biotyper: Identifies microorganisms using mass spectrometry and earns through instrument sales, diagnostic test kits, and software subscriptions.
- Canopy Biosciences: Provides spatial biology instruments and testing services, earning revenue through reagent sales and contracted biomarker research.
- Inscopix: Produces miniature brain-imaging microscopes, selling hardware and imaging consumables to academic and pharmaceutical researchers.
- Chemspeed Technologies: Builds laboratory automation hardware and robotics, earning revenue from custom equipment sales and software licenses.
BRKR’s flags, in plain English
Each flag is a number from Bruker’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 18, 2026.
Insiders Hold
Insiders own 27.2% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Stupid Cash
Can pay this year's bills 1.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Wide Gross Margin
Gross margin of 48% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Burning Cash
Losing money, profit margin of -4.8%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about BRKR
How big is Bruker?
Bruker’s market cap is $9.48B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $3.51B: what customers paid the company over the last year, before any costs.
What is BRKR’s P/E ratio?
BRKR has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with BRKR?
Academic and government research budgets fund a major portion of instrument purchases, leaving sales vulnerable to public spending cuts. That is one risk on Bruker’s card. Its first risk flag is Burning Cash, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Bruker’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BRKR’s filings on SEC.gov. The Margin Monkey is research, not advice.
